Passive immunisation with monoclonal anti-Abeta antibodies for the treatment of Alzheimer's disease

1Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To review systematically the evidence for the efficacy and safety of monoclonal anti-Aβ antibody treatments for Alzheimer's disease.

Cite

CITATION STYLE

APA

Mccleery, J., Molena, E. J., Worrall, R. E., Pflanz, C. P., & Casey, D. (2018). Passive immunisation with monoclonal anti-Abeta antibodies for the treatment of Alzheimer’s disease. Cochrane Database of Systematic Reviews, 2018(8). https://doi.org/10.1002/14651858.CD010188.pub2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free